Neet

Biotechnology And Its Applications

NEET 2022 Phase 1

MCQ+4 / -12022

In gene therapy of Adenosine Deaminase (ADA) deficiency, the patient requires periodic infusion of genetically engineered lymphocytes because:

Continue this paper

Previous questionBiotechnology And Its Applications2022MCQ Next questionBiotechnology And Its Applications2022MCQ

Similar Biotechnology And Its Applications PYQs

Neet questionBiotechnology And Its Applications2026MCQ Neet questionBiotechnology And Its Applications2026MCQ Neet questionBiotechnology And Its Applications2026MCQ Neet questionBiotechnology And Its Applications2025MCQ Neet questionBiotechnology And Its Applications2024MCQ Neet questionBiotechnology And Its Applications2024MCQ

More practice from this question

All Biotechnology And Its Applications PYQsBiology NEET 2022 Phase 12022 Browse Neet chapters